Breaking News

Recipharm Divests Bioanalysis Biz

Expands existing partnership with CTC Clinical Trial Consultants AB.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Recipharm, a CDMO, and CTC Clinical Trial Consultants have expanded their partnership with the divestment of Recipharm’s GLP bioanalysis business to the Center for Translational Research AB (CTR) group. CTR is the Uppsala based parent company of CTC Clinical Trial Consultants.             Recipharm and CTC Clinical Trial Consultants partnered in 2017 to form Recipharma Pathway to Clinic, an integrated service that offers a streamlined pathway to first-in-human milestones. As part of the solutio...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters